Defense Biotechnology Strategy Act
Current understanding
A House bill introduced in the 119th Congress directs the executive branch to develop a defense biotechnology strategy, and has been referred to the House Armed Services and Foreign Affairs committees. The measure would add a defense- and foreign-policy-oriented strategic planning track alongside existing bio-data standards, biosecurity, and biotech diplomacy vehicles. Status: introduced; no committee action yet, so operational effect on developers, platforms, or users remains prospective.
Evidence log
- 2025-11-10 — Defense Biotechnology Strategy Act: cross-connection with biotechnology-diplomacy-innovation-governance: Defense-oriented biotechnology strategy complements the State Department-led biotech diplomacy and senior-official vehicles, extending U.S. biotech governance into the Armed Services jurisdiction. (novelty: 2)